Epanova® for Lowering Very High Triglycerides II (EVOLVE II)
Clinical trial NCT02009865 · COMPLETED
Trial details
- NCT number
- NCT02009865
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-16
- Primary completion
- 2014-12-23
- Enrollment
- 379
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.